Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    June 2024
  1. ELKHOLI IE, Rose AAN, Aguirre-Ghiso JA, Cote JF, et al
    How can we integrate the biology of breast cancer cell dormancy into clinical practice?
    Cancer Cell. 2024 Jun 12:S1535-6108(24)00191-0. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available


  2. LI Y, Huang M, Wang M, Wang Y, et al
    Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.
    Cancer Cell. 2024;42:985-1002.
    PubMed     Abstract available


    May 2024
  3. MCGINNIS CS, Miao Z, Superville D, Yao W, et al
    The temporal progression of lung immune remodeling during breast cancer metastasis.
    Cancer Cell. 2024 May 24:S1535-6108(24)00167-3. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available


  4. LAYER N, Bunse L, Venkataramani V
    Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system.
    Cancer Cell. 2024 May 17:S1535-6108(24)00170-3. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available


    April 2024
  5. LIN CJ, Jin X, Ma D, Chen C, et al
    Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
    Cancer Cell. 2024;42:701-719.
    PubMed     Abstract available


    March 2024
  6. BEJARANO L, Kauzlaric A, Lamprou E, Lourenco J, et al
    Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
    Cancer Cell. 2024;42:378-395.
    PubMed     Abstract available


    January 2024
  7. SHIAO SL, Gouin KH 3rd, Ing N, Ho A, et al
    Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.
    Cancer Cell. 2024;42:70-84.
    PubMed     Abstract available


  8. GODDARD ET, Linde MH, Srivastava S, Klug G, et al
    Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.
    Cancer Cell. 2024;42:119-134.
    PubMed     Abstract available


  9. SHAITELMAN SF, Woodward WA
    Neoadjuvant radioimmunotherapy synergy in triple-negative breast cancer: Is microenvironment-guided patient selection on the horizon?
    Cancer Cell. 2024;42:10-12.
    PubMed     Abstract available


    December 2023
  10. SREEKUMAR A, Lu M, Choudhury B, Pan TC, et al
    B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling.
    Cancer Cell. 2023 Dec 1:S1535-6108(23)00399-9. doi: 10.1016/j.ccell.2023.
    PubMed     Abstract available


    May 2023
  11. HUTTEN SJ, de Bruijn R, Lutz C, Badoux M, et al
    A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.
    Cancer Cell. 2023;41:986-1002.
    PubMed     Abstract available


  12. MAGBANUA MJM, Brown Swigart L, Ahmed Z, Sayaman RW, et al
    Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
    Cancer Cell. 2023 May 3:S1535-6108(23)00134-4. doi: 10.1016/j.ccell.2023.
    PubMed     Abstract available


    April 2023
  13. MOUSSET A, Lecorgne E, Bourget I, Lopez P, et al
    Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-beta activation.
    Cancer Cell. 2023;41:757-775.
    PubMed     Abstract available


    February 2023
  14. VIRASSAMY B, Caramia F, Savas P, Sant S, et al
    Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.
    Cancer Cell. 2023 Feb 8:S1535-6108(23)00004-1. doi: 10.1016/j.ccell.2023.
    PubMed     Abstract available


    December 2022
  15. BLOMBERG OS, Spagnuolo L, Garner H, Voorwerk L, et al
    IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.
    Cancer Cell. 2022 Dec 14:S1535-6108(22)00561-X. doi: 10.1016/j.ccell.2022.
    PubMed     Abstract available


  16. BEHBOD F, Khan SA
    Towards the development of DCIS risk prediction models.
    Cancer Cell. 2022;40:1461-1464.
    PubMed     Abstract available


  17. STRAND SH, Rivero-Gutierrez B, Houlahan KE, Seoane JA, et al
    Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
    Cancer Cell. 2022;40:1521-1536.
    PubMed     Abstract available


  18. GRISARU-TAL S, Munitz A
    T cell-eosinophil crosstalk-A new road for effective immune checkpoint blockade in breast cancer?
    Cancer Cell. 2022 Dec 10:S1535-6108(22)00555-4. doi: 10.1016/j.ccell.2022.
    PubMed     Abstract available


    November 2022
  19. LIU X, Lu Y, Huang J, Xing Y, et al
    CD16(+) fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition.
    Cancer Cell. 2022;40:1341-1357.
    PubMed     Abstract available


    June 2022
  20. DENKERT C, Loibl S
    Response-based molecular subtyping-emergence of the third generation of breast cancer subtypes.
    Cancer Cell. 2022;40:592-594.
    PubMed     Abstract available


    May 2022
  21. WOLF DM, Yau C, Wulfkuhle J, Brown-Swigart L, et al
    Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
    Cancer Cell. 2022 May 25. pii: S1535-6108(22)00216.
    PubMed     Abstract available


    November 2021
  22. KOH SB, Ellisen LW
    Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancer.
    Cancer Cell. 2021 Nov 8. pii: S1535-6108(21)00601.
    PubMed     Abstract available


    October 2021
  23. ZHANG Y, Chen H, Mo H, Hu X, et al
    Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.
    Cancer Cell. 2021 Oct 5. pii: S1535-6108(21)00499.
    PubMed     Abstract available


    September 2021
  24. SHIAO SL, Kershaw KM, Limon JJ, You S, et al
    Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.
    Cancer Cell. 2021;39:1202-1213.
    PubMed     Abstract available


    August 2021
  25. HANKER AB, Brown BP, Meiler J, Marin A, et al
    Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.
    Cancer Cell. 2021;39:1099-1114.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.